Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study.

Maher TM, Stowasser S, Nishioka Y, White ES, Cottin V, Noth I, Selman M, Rohr KB, Michael A, Ittrich C, Diefenbach C, Jenkins RG; INMARK trial investigators.

Lancet Respir Med. 2019 Jul 17. pii: S2213-2600(19)30255-3. doi: 10.1016/S2213-2600(19)30255-3. [Epub ahead of print]

PMID:
31326319
2.

Routine Chest Radiography for the Evaluation of Pneumothorax Following Bronchoscopy.

Centonze CP, Davenport MS, White ES, Kazerooni EA.

Acad Radiol. 2019 May;26(5):585-590. doi: 10.1016/j.acra.2018.11.025.

PMID:
31047101
3.

The Fibrosis Across Organs Symposium: A Roadmap for Future Research Priorities.

Roman J, Barnes TR, Kervitsky DJ, Cosgrove GP, Doherty DE, Tager AM, Richeldi L, White ES, Brenner DA, Schnapp LM, Hewitson TD, Jugdutt BI, McKinsey TA, Tosi JD, Crane S, Brown KK; Fibrosis Across Organs Symposium Working Group.

Am J Med Sci. 2019 May;357(5):405-410. doi: 10.1016/j.amjms.2019.02.014. No abstract available.

4.

Frailty and geriatric conditions in older patients with idiopathic pulmonary fibrosis.

Sheth JS, Xia M, Murray S, Martinez CH, Meldrum CA, Belloli EA, Salisbury ML, White ES, Holtze CH, Flaherty KR.

Respir Med. 2019 Mar;148:6-12. doi: 10.1016/j.rmed.2019.01.008. Epub 2019 Jan 24.

PMID:
30827476
5.

Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.

O'Dwyer DN, Ashley SL, Gurczynski SJ, Xia M, Wilke C, Falkowski NR, Norman KC, Arnold KB, Huffnagle GB, Salisbury ML, Han MK, Flaherty KR, White ES, Martinez FJ, Erb-Downward JR, Murray S, Moore BB, Dickson RP.

Am J Respir Crit Care Med. 2019 May 1;199(9):1127-1138. doi: 10.1164/rccm.201809-1650OC.

PMID:
30789747
6.

Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis.

Young A, Vummidi D, Visovatti S, Homer K, Wilhalme H, White ES, Flaherty K, McLaughlin V, Khanna D.

Arthritis Rheumatol. 2019 Feb 14. doi: 10.1002/art.40862. [Epub ahead of print]

PMID:
30762947
7.

αvβ3 Integrin drives fibroblast contraction and strain stiffening of soft provisional matrix during progressive fibrosis.

Fiore VF, Wong SS, Tran C, Tan C, Xu W, Sulchek T, White ES, Hagood JS, Barker TH.

JCI Insight. 2018 Oct 18;3(20). pii: 97597. doi: 10.1172/jci.insight.97597.

8.

Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory.

Salisbury ML, Gu T, Murray S, Gross BH, Chughtai A, Sayyouh M, Kazerooni EA, Myers JL, Lagstein A, Konopka KE, Belloli EA, Sheth JS, White ES, Holtze C, Martinez FJ, Flaherty KR.

Chest. 2019 Apr;155(4):699-711. doi: 10.1016/j.chest.2018.08.1076. Epub 2018 Sep 19.

PMID:
30243979
9.

Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial.

Maher TM, Stowasser S, Nishioka Y, White ES, Cottin V, Noth I, Selman M, Blahova Z, Wachtlin D, Diefenbach C, Jenkins RG.

BMJ Open Respir Res. 2018 Aug 20;5(1):e000325. doi: 10.1136/bmjresp-2018-000325. eCollection 2018.

10.

Wilms' tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease.

Sontake V, Kasam RK, Sinner D, Korfhagen TR, Reddy GB, White ES, Jegga AG, Madala SK.

JCI Insight. 2018 Aug 23;3(16). pii: 121252. doi: 10.1172/jci.insight.121252. eCollection 2018 Aug 23.

11.

Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis.

Salisbury ML, Gross BH, Chughtai A, Sayyouh M, Kazerooni EA, Bartholmai BJ, Xia M, Murray S, Myers JL, Lagstein A, Konopka KE, Belloli EA, Sheth JS, White ES, Holtze C, Martinez FJ, Flaherty KR.

Eur Respir J. 2018 Aug 16;52(2). pii: 1800443. doi: 10.1183/13993003.00443-2018. Print 2018 Aug.

PMID:
29946001
12.

FOXM1 is a critical driver of lung fibroblast activation and fibrogenesis.

Penke LR, Speth JM, Dommeti VL, White ES, Bergin IL, Peters-Golden M.

J Clin Invest. 2018 Jun 1;128(6):2389-2405. doi: 10.1172/JCI87631. Epub 2018 May 7.

13.

Discoidin Domain Receptor 2 Signaling Regulates Fibroblast Apoptosis through PDK1/Akt.

Jia S, Agarwal M, Yang J, Horowitz JC, White ES, Kim KK.

Am J Respir Cell Mol Biol. 2018 Sep;59(3):295-305. doi: 10.1165/rcmb.2017-0419OC.

PMID:
29652518
14.

Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis.

de Brouwer B, Drent M, van den Ouweland JMW, Wijnen PA, van Moorsel CHM, Bekers O, Grutters JC, White ES, Janssen R.

Respir Res. 2018 Mar 20;19(1):45. doi: 10.1186/s12931-018-0747-6.

15.

Extracellular matrix in lung development, homeostasis and disease.

Zhou Y, Horowitz JC, Naba A, Ambalavanan N, Atabai K, Balestrini J, Bitterman PB, Corley RA, Ding BS, Engler AJ, Hansen KC, Hagood JS, Kheradmand F, Lin QS, Neptune E, Niklason L, Ortiz LA, Parks WC, Tschumperlin DJ, White ES, Chapman HA, Thannickal VJ.

Matrix Biol. 2018 Nov;73:77-104. doi: 10.1016/j.matbio.2018.03.005. Epub 2018 Mar 8. Review.

PMID:
29524630
16.

Loss of CDKN2B Promotes Fibrosis via Increased Fibroblast Differentiation Rather Than Proliferation.

Scruggs AM, Koh HB, Tripathi P, Leeper NJ, White ES, Huang SK.

Am J Respir Cell Mol Biol. 2018 Aug;59(2):200-214. doi: 10.1165/rcmb.2017-0298OC.

PMID:
29420051
17.

The fibronectin ED-A domain enhances recruitment of latent TGF-β-binding protein-1 to the fibroblast matrix.

Klingberg F, Chau G, Walraven M, Boo S, Koehler A, Chow ML, Olsen AL, Im M, Lodyga M, Wells RG, White ES, Hinz B.

J Cell Sci. 2018 Mar 1;131(5). pii: jcs201293. doi: 10.1242/jcs.201293.

18.

Correction: Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis (doi: 10.1242/dmm.030114).

Tjin G, White ES, Faiz A, Sicard D, Tschumperlin DJ, Mahar A, Kable EPW, Burgess JK.

Dis Model Mech. 2017 Dec 19;10(12):1545. doi: 10.1242/dmm.033191. No abstract available.

19.

In Vitro Induction and In Vivo Engraftment of Lung Bud Tip Progenitor Cells Derived from Human Pluripotent Stem Cells.

Miller AJ, Hill DR, Nagy MS, Aoki Y, Dye BR, Chin AM, Huang S, Zhu F, White ES, Lama V, Spence JR.

Stem Cell Reports. 2018 Jan 9;10(1):101-119. doi: 10.1016/j.stemcr.2017.11.012. Epub 2017 Dec 14.

20.

Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis.

Tjin G, White ES, Faiz A, Sicard D, Tschumperlin DJ, Mahar A, Kable EPW, Burgess JK.

Dis Model Mech. 2017 Nov 1;10(11):1301-1312. doi: 10.1242/dmm.030114. Erratum in: Dis Model Mech. 2017 Dec 19;10 (12 ):1545.

21.

Bioengineered lungs generated from human iPSCs-derived epithelial cells on native extracellular matrix.

Ghaedi M, Le AV, Hatachi G, Beloiartsev A, Rocco K, Sivarapatna A, Mendez JJ, Baevova P, Dyal RN, Leiby KL, White ES, Niklason LE.

J Tissue Eng Regen Med. 2018 Mar;12(3):e1623-e1635. doi: 10.1002/term.2589. Epub 2017 Nov 28.

22.

Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, Birnie DH, Chen ES, Cooper LT, Tung RH, White ES, Borges-Neto S, Di Carli MF, Gropler RJ, Ruddy TD, Schindler TH, Blankstein R.

J Nucl Cardiol. 2017 Oct;24(5):1741-1758. doi: 10.1007/s12350-017-0978-9. No abstract available.

PMID:
28770463
23.

Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.

Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, Birnie DH, Chen ES, Cooper LT, Tung RH, White ES, Borges-Neto S, Di Carli MF, Gropler RJ, Ruddy TD, Schindler TH, Blankstein R; NAME OF COLLAB GROUP.

J Nucl Med. 2017 Aug;58(8):1341-1353. doi: 10.2967/jnumed.117.196287. No abstract available.

24.

The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease.

Burgstaller G, Oehrle B, Gerckens M, White ES, Schiller HB, Eickelberg O.

Eur Respir J. 2017 Jul 5;50(1). pii: 1601805. doi: 10.1183/13993003.01805-2016. Print 2017 Jul. Review.

25.

Erratum: The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes.

O'Dwyer DN, Norman KC, Xia M, Huang Y, Gurczynski SJ, Ashley SL, White ES, Flaherty KR, Martinez FJ, Murray S, Noth I, Arnold KB, Moore BB.

Sci Rep. 2017 Jun 30;7:46860. doi: 10.1038/srep46860.

26.

An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells.

Zaidi SK, Perez AW, White ES, Lian JB, Stein JL, Stein GS.

Oncotarget. 2017 Jun 20;8(25):39994-40005. doi: 10.18632/oncotarget.18127.

27.

An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis.

Jenkins RG, Moore BB, Chambers RC, Eickelberg O, Königshoff M, Kolb M, Laurent GJ, Nanthakumar CB, Olman MA, Pardo A, Selman M, Sheppard D, Sime PJ, Tager AM, Tatler AL, Thannickal VJ, White ES; ATS Assembly on Respiratory Cell and Molecular Biology.

Am J Respir Cell Mol Biol. 2017 May;56(5):667-679. doi: 10.1165/rcmb.2017-0096ST.

28.

The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes.

O'Dwyer DN, Norman KC, Xia M, Huang Y, Gurczynski SJ, Ashley SL, White ES, Flaherty KR, Martinez FJ, Murray S, Noth I, Arnold KB, Moore BB.

Sci Rep. 2017 Apr 25;7:46560. doi: 10.1038/srep46560. Erratum in: Sci Rep. 2017 Jun 30;7:46860.

29.

MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis.

Bauer Y, White ES, de Bernard S, Cornelisse P, Leconte I, Morganti A, Roux S, Nayler O.

ERJ Open Res. 2017 Mar 22;3(1). pii: 00074-2016. doi: 10.1183/23120541.00074-2016. eCollection 2017 Jan.

30.

Hsp90 regulation of fibroblast activation in pulmonary fibrosis.

Sontake V, Wang Y, Kasam RK, Sinner D, Reddy GB, Naren AP, McCormack FX, White ES, Jegga AG, Madala SK.

JCI Insight. 2017 Feb 23;2(4):e91454. doi: 10.1172/jci.insight.91454.

31.

Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis.

Huang Y, Ma SF, Espindola MS, Vij R, Oldham JM, Huffnagle GB, Erb-Downward JR, Flaherty KR, Moore BB, White ES, Zhou T, Li J, Lussier YA, Han MK, Kaminski N, Garcia JGN, Hogaboam CM, Martinez FJ, Noth I; COMET-IPF Investigators.

Am J Respir Crit Care Med. 2017 Jul 15;196(2):208-219. doi: 10.1164/rccm.201607-1525OC.

32.

The diagnosis of idiopathic pulmonary fibrosis: current and future approaches.

Martinez FJ, Chisholm A, Collard HR, Flaherty KR, Myers J, Raghu G, Walsh SL, White ES, Richeldi L.

Lancet Respir Med. 2017 Jan;5(1):61-71. doi: 10.1016/S2213-2600(16)30325-3. Epub 2016 Dec 6. Review.

33.

A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids.

Dye BR, Dedhia PH, Miller AJ, Nagy MS, White ES, Shea LD, Spence JR.

Elife. 2016 Sep 28;5. pii: e19732. doi: 10.7554/eLife.19732.

34.

Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease.

Sheth JS, Belperio JA, Fishbein MC, Kazerooni EA, Lagstein A, Murray S, Myers JL, Simon RH, Sisson TH, Sundaram B, White ES, Xia M, Zisman D, Flaherty KR.

Chest. 2017 Feb;151(2):389-399. doi: 10.1016/j.chest.2016.09.028. Epub 2016 Oct 8.

35.

Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.

Ashley SL, Xia M, Murray S, O'Dwyer DN, Grant E, White ES, Flaherty KR, Martinez FJ, Moore BB.

PLoS One. 2016 Aug 4;11(8):e0159878. doi: 10.1371/journal.pone.0159878. eCollection 2016.

36.

Comparative biology of decellularized lung matrix: Implications of species mismatch in regenerative medicine.

Balestrini JL, Gard AL, Gerhold KA, Wilcox EC, Liu A, Schwan J, Le AV, Baevova P, Dimitrievska S, Zhao L, Sundaram S, Sun H, Rittié L, Dyal R, Broekelmann TJ, Mecham RP, Schwartz MA, Niklason LE, White ES.

Biomaterials. 2016 Sep;102:220-30. doi: 10.1016/j.biomaterials.2016.06.025. Epub 2016 Jun 16.

37.

Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.

White ES, Xia M, Murray S, Dyal R, Flaherty CM, Flaherty KR, Moore BB, Cheng L, Doyle TJ, Villalba J, Dellaripa PF, Rosas IO, Kurtis JD, Martinez FJ.

Am J Respir Crit Care Med. 2016 Nov 15;194(10):1242-1251.

38.

Commentary: A Breath of Fresh Air on the Mesenchyme: Impact of Impaired Mesenchymal Development on the Pathogenesis of Bronchopulmonary Dysplasia.

White ES.

Front Med (Lausanne). 2016 Mar 31;3:13. doi: 10.3389/fmed.2016.00013. eCollection 2016. No abstract available.

39.

An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research.

White ES, Borok Z, Brown KK, Eickelberg O, Guenther A, Jenkins RG, Kolb M, Martinez FJ, Roman J, Sime P; American Thoracic Society Respiratory Cell and Molecular Biology Assembly Working Group on Pulmonary Fibrosis.

Am J Respir Crit Care Med. 2016 Apr 1;193(7):792-800. doi: 10.1164/rccm.201602-0254ST.

40.

A Mixed Methods Approach to Equity and Justice Research: Insights from Research on Children's Reasoning About Economic Inequality.

Mistry RS, White ES, Chow KA, Griffin KM, Nenadal L.

Adv Child Dev Behav. 2016;50:209-36. doi: 10.1016/bs.acdb.2015.11.003. Epub 2016 Jan 27. Review.

PMID:
26956075
41.

Fifty years of longitudinal continuity in general practice: a retrospective observational study.

White ES, Pereira Gray D, Langley P, Evans PH.

Fam Pract. 2016 Apr;33(2):148-53. doi: 10.1093/fampra/cmw001. Epub 2016 Feb 19.

PMID:
26895634
42.

Mucking around in the Genome: MUC5B in Idiopathic Pulmonary Fibrosis.

Kolb M, White ES, Gauldie J.

Am J Respir Crit Care Med. 2016 Feb 15;193(4):355-7. doi: 10.1164/rccm.201512-2360ED. No abstract available.

PMID:
26871671
43.

IL-36γ is secreted in microparticles and exosomes by lung macrophages in response to bacteria and bacterial components.

Kovach MA, Singer BH, Newstead MW, Zeng X, Moore TA, White ES, Kunkel SL, Peters-Golden M, Standiford TJ.

J Leukoc Biol. 2016 Aug;100(2):413-21. doi: 10.1189/jlb.4A0315-087R. Epub 2016 Feb 10.

44.

Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.

Sun H, Zhu Y, Pan H, Chen X, Balestrini JL, Lam TT, Kanyo JE, Eichmann A, Gulati M, Fares WH, Bai H, Feghali-Bostwick CA, Gan Y, Peng X, Moore MW, White ES, Sava P, Gonzalez AL, Cheng Y, Niklason LE, Herzog EL.

Arthritis Rheumatol. 2016 May;68(5):1251-61. doi: 10.1002/art.39575.

45.

Plakoglobin expression in fibroblasts and its role in idiopathic pulmonary fibrosis.

Matthes SA, LaRouere TJ, Horowitz JC, White ES.

BMC Pulm Med. 2015 Nov 6;15:140. doi: 10.1186/s12890-015-0137-5.

46.

Animal and cellular models of human disease.

Arends MJ, White ES, Whitelaw CB.

J Pathol. 2016 Jan;238(2):137-40. doi: 10.1002/path.4662.

PMID:
26482929
47.

Conformational coupling of integrin and Thy-1 regulates Fyn priming and fibroblast mechanotransduction.

Fiore VF, Strane PW, Bryksin AV, White ES, Hagood JS, Barker TH.

J Cell Biol. 2015 Oct 12;211(1):173-90. doi: 10.1083/jcb.201505007.

48.

Generation of tissue-engineered small intestine using embryonic stem cell-derived human intestinal organoids.

Finkbeiner SR, Freeman JJ, Wieck MM, El-Nachef W, Altheim CH, Tsai YH, Huang S, Dyal R, White ES, Grikscheit TC, Teitelbaum DH, Spence JR.

Biol Open. 2015 Oct 12;4(11):1462-72. doi: 10.1242/bio.013235.

49.

Recommendations for minimum information for publication of experimental pathology data: MINPEPA guidelines.

Scudamore CL, Soilleux EJ, Karp NA, Smith K, Poulsom R, Herrington CS, Day MJ, Brayton CF, Bolon B, Whitelaw B, White ES, Everitt JI, Arends MJ.

J Pathol. 2016 Jan;238(2):359-67. doi: 10.1002/path.4642. Epub 2015 Nov 28. Review.

PMID:
26387837
50.

Fibrocytes Regulate Wilms Tumor 1-Positive Cell Accumulation in Severe Fibrotic Lung Disease.

Sontake V, Shanmukhappa SK, DiPasquale BA, Reddy GB, Medvedovic M, Hardie WD, White ES, Madala SK.

J Immunol. 2015 Oct 15;195(8):3978-91. doi: 10.4049/jimmunol.1500963. Epub 2015 Sep 14.

Supplemental Content

Loading ...
Support Center